0

MCQ#18

Question-Mark

Ipilimumab, Pembrolizumab and Nivolumab being used in melanoma treatment target:

a) Natural Killer cells

b) T-cell activating receptors

c) T-cell inhibitory receptors

d) B-cells

Click here for Answer